GlassScriptPhysician profile
Anne M Dobrzynski
NPI 1114012382
$316.84
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $61.19 · 2021: $18.23 · 2022: $22.93.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $134.23 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $54.03 | 2019 | |
| Avion Pharmaceuticals | $38.11 | 2019 | |
| Daiichi Sankyo INC. | $19.08 | 2019 | |
| Amgen INC. | $18.23 | 2021 | |
| Therapeuticsmd, INC. | $17.28 | 2019 | |
| Vertical Pharmaceuticals, LLC | $13.65 | 2019 | |
| Allergan, INC. | $11.16 | 2019 | |
| Coopersurgical, INC. | $11.07 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Dobrzynski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.